Literature DB >> 18349127

Induction of an epithelial integrin alphavbeta6 in human cytomegalovirus-infected endothelial cells leads to activation of transforming growth factor-beta1 and increased collagen production.

Takako Tabata1, Hisaaki Kawakatsu, Ekaterina Maidji, Takao Sakai, Keiko Sakai, June Fang-Hoover, Motohiko Aiba, Dean Sheppard, Lenore Pereira.   

Abstract

Human cytomegalovirus (CMV) infection is a major cause of morbidity in immunosuppressed individuals, and congenital CMV infection is a leading cause of birth defects in newborns. Infection with pathogenic viral strains alters cell-cell and cell-matrix interactions, affecting extracellular matrix remodeling and endothelial cell migration. The multifunctional cytokine transforming growth factor (TGF)-beta1 regulates cell proliferation, differentiation, and extracellular matrix remodeling. Secreted as a latent protein complex, TGF-beta1 requires activation before binding to receptors that phosphorylate intracellular effectors. TGF-beta1 is activated by integrin alphavbeta6, which is strongly induced in the epithelium by injury and inflammation but has not previously been found in endothelial cells. Here, we report that CMV infection induces integrin alphavbeta6 expression in endothelial cells, leading to activation of TGF-beta1, signaling through its receptor ALK5, and phosphorylation of its intracellular effector Smad3. Infection of endothelial cells was also found to stimulate collagen synthesis through a mechanism dependent on both TGF-beta1 and integrin alphavbeta6. Immunohistochemical analysis showed integrin alphavbeta6 up-regulation in capillaries proximal to foci of CMV infection in lungs, salivary glands, uterine decidua, and injured chorionic villi of the placenta, demonstrating both its induction in endothelium and up-regulation in epithelium in vivo. Our results suggest that activation of TGF-beta1 by integrin alphavbeta6 contributes to pathological changes and may impair endothelial cell functions in tissues that are chronically infected with CMV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18349127      PMCID: PMC2276431          DOI: 10.2353/ajpath.2008.070448

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  77 in total

Review 1.  Infection in organ-transplant recipients.

Authors:  J A Fishman; R H Rubin
Journal:  N Engl J Med       Date:  1998-06-11       Impact factor: 91.245

2.  Interactions between growth factors and integrins: latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1.

Authors:  J S Munger; J G Harpel; F G Giancotti; D B Rifkin
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

Review 3.  Cell types involved in replication and distribution of human cytomegalovirus.

Authors:  B Plachter; C Sinzger; G Jahn
Journal:  Adv Virus Res       Date:  1996       Impact factor: 9.937

4.  Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.

Authors:  N P Barbara; J L Wrana; M Letarte
Journal:  J Biol Chem       Date:  1999-01-08       Impact factor: 5.157

5.  Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

Authors:  S E Crawford; V Stellmach; J E Murphy-Ullrich; S M Ribeiro; J Lawler; R O Hynes; G P Boivin; N Bouck
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

6.  Expression of the human integrin beta6 subunit in alveolar type II cells and bronchiolar epithelial cells reverses lung inflammation in beta6 knockout mice.

Authors:  X Huang; J Wu; W Zhu; R Pytela; D Sheppard
Journal:  Am J Respir Cell Mol Biol       Date:  1998-10       Impact factor: 6.914

7.  The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta1 gene through an Egr-1 binding site.

Authors:  Y D Yoo; C J Chiou; K S Choi; Y Yi; S Michelson; S Kim; G S Hayward; S J Kim
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

8.  Inactivation of the integrin beta 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin.

Authors:  X Z Huang; J F Wu; D Cass; D J Erle; D Corry; S G Young; R V Farese; D Sheppard
Journal:  J Cell Biol       Date:  1996-05       Impact factor: 10.539

9.  Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling.

Authors:  J M Breuss; J Gallo; H M DeLisser; I V Klimanskaya; H G Folkesson; J F Pittet; S L Nishimura; K Aldape; D V Landers; W Carpenter
Journal:  J Cell Sci       Date:  1995-06       Impact factor: 5.285

10.  The integrin alphavbeta6 is critical for keratinocyte migration on both its known ligand, fibronectin, and on vitronectin.

Authors:  X Huang; J Wu; S Spong; D Sheppard
Journal:  J Cell Sci       Date:  1998-08       Impact factor: 5.285

View more
  21 in total

1.  Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection.

Authors:  Lenore Pereira; Matthew Petitt; Alex Fong; Mitsuru Tsuge; Takako Tabata; June Fang-Hoover; Ekaterina Maidji; Martin Zydek; Yan Zhou; Naoki Inoue; Sanam Loghavi; Samuel Pepkowitz; Lawrence M Kauvar; Dotun Ogunyemi
Journal:  J Infect Dis       Date:  2014-01-07       Impact factor: 5.226

2.  Cytomegalovirus infection and antibody protection of the developing placenta.

Authors:  Lenore Pereira; Matthew Petitt; Takako Tabata
Journal:  Clin Infect Dis       Date:  2013-12       Impact factor: 9.079

3.  Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection.

Authors:  Ekaterina Maidji; Giovanni Nigro; Takako Tabata; Susan McDonagh; Naoki Nozawa; Stephen Shiboski; Stefania Muci; Maurizio M Anceschi; Natali Aziz; Stuart P Adler; Lenore Pereira
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

4.  Inhibition of NF-kappaB signaling reduces virus load and gammaherpesvirus-induced pulmonary fibrosis.

Authors:  Laurie T Krug; Edilson Torres-González; Qianhong Qin; Dan Sorescu; Mauricio Rojas; Arlene Stecenko; Samuel H Speck; Ana L Mora
Journal:  Am J Pathol       Date:  2010-06-21       Impact factor: 4.307

Review 5.  Models of vertical cytomegalovirus (CMV) transmission and pathogenesis.

Authors:  Yiska Weisblum; Amos Panet; Ronit Haimov-Kochman; Dana G Wolf
Journal:  Semin Immunopathol       Date:  2014-10-08       Impact factor: 9.623

6.  Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture.

Authors:  Yiska Weisblum; Amos Panet; Zichria Zakay-Rones; Ronit Haimov-Kochman; Debra Goldman-Wohl; Ilana Ariel; Haya Falk; Shira Natanson-Yaron; Miri D Goldberg; Ronit Gilad; Nell S Lurain; Caryn Greenfield; Simcha Yagel; Dana G Wolf
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

Review 7.  The story of human cytomegalovirus and cancer: increasing evidence and open questions.

Authors:  Martin Michaelis; Hans W Doerr; Jindrich Cinatl
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

8.  Zika Virus Replicates in Proliferating Cells in Explants From First-Trimester Human Placentas, Potential Sites for Dissemination of Infection.

Authors:  Takako Tabata; Matthew Petitt; Henry Puerta-Guardo; Daniela Michlmayr; Eva Harris; Lenore Pereira
Journal:  J Infect Dis       Date:  2018-03-28       Impact factor: 5.226

9.  Twist: a regulator of epithelial-mesenchymal transition in lung fibrosis.

Authors:  Veronika Pozharskaya; Edilson Torres-González; Mauricio Rojas; Anthony Gal; Minal Amin; Sheila Dollard; Jesse Roman; Arlene A Stecenko; Ana L Mora
Journal:  PLoS One       Date:  2009-10-23       Impact factor: 3.240

10.  Effects of intrapulmonary viral tropism and cytokine expression on the histological patterns of cytomegalovirus pneumonia.

Authors:  Yoshifumi Arai; Takashi Tsuchida; Isao Kosugi; Hideya Kawasaki; Shiori Meguro; Mana Kinoshita; Satoshi Baba; Matsuyoshi Maeda; Yuichiro Shinmura; Yoshihiro Tsutsui; Toshihide Iwashita
Journal:  Pathol Int       Date:  2012-09       Impact factor: 2.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.